Dr. Jürg Geigy
Dr. Jürg (George) F. Geigy (Vice-President of BioBac) is an independent consult-ant for venture capital investments. He is based in Basel, Switzerland.
He was a manager of NMT New Medical Technologies until this CHF 300 million venture fund was merged into HBM Bioventures in 2003. He was a director, advisor and investor to several venture capital funds and companies including Biogen in its early years until 1982.
Previous professional experiences include head of M&A and Board of Rothschild Bank in Zurich, Bank Julius Bär (management committee and head international M&A), Ciba-Geigy (treasurer) and Dean Witter (financial analyst).
He has studied law at the University of Basel and passed the Basel bar examen.